275 related articles for article (PubMed ID: 4598691)
1. BCG and cancer.
Bast RC; Zbar B; Borsos T; Rapp HJ
N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
[No Abstract] [Full Text] [Related]
2. BCG in the therapy of cancer.
Delmonte L; Oettgen HF
Clin Bull; 1975; 5(2):69-71. PubMed ID: 776445
[No Abstract] [Full Text] [Related]
3. [Immunotherapy of cancer with BCG].
Yamamura Y; Azuma I
Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
[No Abstract] [Full Text] [Related]
4. Use of BCG in the treatment of human neoplasms: a review.
Nathanson L
Semin Oncol; 1974 Dec; 1(4):337-50. PubMed ID: 4620439
[No Abstract] [Full Text] [Related]
5. Immunotherapy of leukemia and lymphoma.
Murphy S; Hersh E
Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506
[No Abstract] [Full Text] [Related]
6. Treatment of malignant melanoma by intratumoral injection of BCG.
Pinsky CM; Hirshaut Y; Oettgen HF
Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
[No Abstract] [Full Text] [Related]
7. Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.
Schwarz MA; Gutterman JU; Hersh EM; Richman SP; Mavligit GM
World J Surg; 1977 Sep; 1(5):555-83. PubMed ID: 272083
[No Abstract] [Full Text] [Related]
8. Immunotherapy for malignant disease.
Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519
[No Abstract] [Full Text] [Related]
9. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
10. Cancer immunotherapy.
Richman SP; Gutterman JU; Hersh EM
Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776
[TBL] [Abstract][Full Text] [Related]
11. Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.
Mastrangelo MJ; Berd D; Bellet RE
Ann N Y Acad Sci; 1976; 277(00):94-123. PubMed ID: 793490
[No Abstract] [Full Text] [Related]
12. Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives.
Klein E; Holtermann OA; Papermaster B; Milgrom H; Rosner D; Klein L; Walker MJ; Zbar B
Natl Cancer Inst Monogr; 1973 Dec; 39():229-42. PubMed ID: 4595323
[No Abstract] [Full Text] [Related]
13. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
Chaparas SD; Chirigos M; Pearson J; Sher N
Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
[No Abstract] [Full Text] [Related]
14. Immunotherapy of acute myelogenous leukemia in man.
Powles R
Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
[No Abstract] [Full Text] [Related]
15. Immunotherapy in previously treated acute lymphatic leukemia.
Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
[No Abstract] [Full Text] [Related]
16. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
17. Complications of BCG vaccination in neoplastic disease.
Aungst CW; Sokal JE; Jager BV
Ann Intern Med; 1975 May; 82(5):666-9. PubMed ID: 1056158
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of chronic myelocytic leukemia.
Sokal JE; Aungst CW; Grace JT
Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
[No Abstract] [Full Text] [Related]
19. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
[No Abstract] [Full Text] [Related]
20. Results of treatment of acute leukaemias with BCG vaccine.
Kardaszewicz E; Japa J
J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):20-4. PubMed ID: 1063220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
